TIGLUTIK
NDC 11797-210, Riluzole, suspension, from Italfarmaco SPA.
- Product NDC
- 11797-210
- Status
- Listed
- Labeler
- Italfarmaco SPA
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA209080
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11797-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RILUZOLE50 mg/10mL
Pharmacologic classes
Benzothiazole [EPC]; Benzothiazoles [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11797-210-01 | 11797021001 | 2 BOTTLE, PLASTIC in 1 CARTON (11797-210-01) / 300 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/20b7165a-eb4d-42a0-b2d8-16eff90a214e
Use it
Look up 11797-210 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11797-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11797-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.